2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Treatment Outcome: new trials by email Literature Review of Treatment Outcome trials Research Report on Treatment Outcome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions Mucopolysaccharide saline solution 0.9%, Saline solution 0.9% - Endoscopic Mucosal Resection, Colonic Neoplasms | Phase 3 | Completed | Nakafarma S.L. | 52 | 2021-01-18 | 2025-04-09 |
| Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction Vortioxetine, Escitalopram, Placebo - Treatment Outcome | Phase 3 | Completed | Takeda | 447 | 2011-06-01 | 2014-10-09 |
Colonic Neoplasms (1) · Depression (1) · Depressive Disorder, Major (1) · Sexual Dysfunction, Physiological (1)
Behavior (1) · Behavioral Symptoms (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Depressive Disorder (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Mental Disorders (1) · Mood Disorders (1) · Neoplasms (1)
Escitalopram (1) · Saline Solution (1) · Vortioxetine (1)
Nakafarma S.L. (1) · Takeda (1)
Canada (1) · Spain (1) · United States (1)
Jose Antonio Morales Molina, PhD in Pharmacy (1)